Janne Petersen

Medicine & Life Sciences

1. Adipose Tissue 33%
2. Age of Onset 26%
3. Amputation 39%
4. Atopic Dermatitis 27%
5. Bupivacaine 45%
6. C-Reactive Protein 25%
7. Cardiovascular Diseases 25%
8. Child 29%
9. Cohort Studies 22%
10. Community-Acquired Infections 23%
11. Creatinine 31%
12. Cystatin C 33%
13. Denmark 45%
14. Drug Prescriptions 37%
15. Elderly 27%
16. Failure to Thrive 25%
17. Glomerular Filtration Rate 38%
18. Hand Strength 26%
19. Health 29%
20. HIV 37%
21. Hospital Emergency Service 34%
22. Hospitalization 59%
23. Inflammation 55%
24. Interleukin-6 21%
25. Kidney 21%
26. Knee Replacement Arthroplasties 27%
27. Lipodystrophy 39%
28. Lower Extremity 30%
29. macrophage migration inhibitory factor receptor 25%
30. Macrophage Migration-Inhibitory Factors 30%
31. Mortality 31%
32. Multimorbidity 36%
33. Muscles 25%
34. Mutation 20%
35. Myocardial Ischemia 21%
36. neutrophil migration inhibitory factor 27%
37. Pain 21%
38. Physical Functional Performance 63%
39. Population 42%
40. Potentially Inappropriate Medication List 24%
41. Public Health Nurses 38%
42. Randomized Controlled Trials 45%
43. Registries 22%
44. Resistance Training 66%
45. Respite Care 21%
46. Stomatitis 32%
47. Systemic Inflammatory Response Syndrome 41%
48. Triggering Receptor Expressed on Myeloid Cells-1 36%
49. Urokinase Plasminogen Activator Receptors 100%
50. Walking Speed 28%